GHRP-2 (Growth Hormone Releasing Peptide-2) – Peptide Vial 5 mg

Product Description:

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic peptide designed to stimulate the body’s natural growth hormone (GH) secretion by activating ghrelin receptors. Each vial contains 5 mg of GHRP-2, reconstituted with sterile water before use.

Widely used in bodybuilding and performance enhancement, GHRP-2 helps with muscle growth, fat metabolism, recovery, and appetite stimulation, making it effective for both bulking and recovery phases.

Key Features

• Active Ingredient: GHRP-2 (Growth Hormone Releasing Peptide-2)

• Form: Lyophilized peptide (5 mg) + Sterile water for reconstitution

• Category: Growth Hormone Releasing Peptide (GHRP)

• Administration: Subcutaneous or intramuscular injection after reconstitution

How GHRP-2 Works

• Activates ghrelin receptors, stimulating the pituitary gland to release growth hormone

• Enhances protein synthesis and recovery after training

• Improves fat metabolism, supporting a leaner physique

• Increases IGF-1 production, aiding in muscle repair and regeneration

• Boosts sleep quality and overall recovery

Uses & Benefits of GHRP-2

• Muscle Growth & Recovery: Supports faster repair and lean mass development

• Fat Metabolism: Enhances fat burning and promotes a leaner body composition

• Improved Sleep: Deepens rest and accelerates recovery

• Increased Appetite: Useful for bulking and muscle-building phases

Dosage & Administration

• Typical Dosage: 100–300 mcg per injection, 2–3 times daily

• Injection Timing: Often taken in the morning, post-workout, and before sleep

• Cycle Duration: 4–12 weeks depending on goals

• Stacking: Commonly combined with other peptides such as CJC-1295 or Ipamorelin for enhanced results

Possible Side Effects of GHRP-2

While generally well-tolerated, some users may experience:

• Mild water retention

• Temporary tingling or numbness in extremities

• Increased hunger

• Fluctuations in blood glucose levels

Who Should Avoid GHRP-2?

• Pregnant or breastfeeding women

• Individuals with pituitary or endocrine disorders

• Cancer patients (due to GH stimulation risks)

• Users under 21 years of age